Mark Payton News Today

Tonight on 7 a mile high let down. The denver defense gets the ball back for the broncos. Fooled tom brady. He reversed field. Looked inside. Interception. Its the end of the road for the pats in the play offs. ; the patriots recovering from a tough loss out in denver. Anchor tom brady keeping interesting until the final minute of the game. All the team needed was a 2 upon point conversion to tie it up. Hearing from brady and gronkowski. Live in denver with what the team had to say. Reporter pat...

Former pupils of a boarding school where boys with haemophilia were infected with contaminated blood have said they were told to "carry on as normal" as their peers became sick.

Some 3,000 people have died and others left with lifelong health complications after being infected with viruses including hepatitis C and HIV

Mercia Asset Management PLC on Wednesday said it had achieved a record level of organic fund inflows in its latest financial year in the face of a challenging market backdrop. In the year ended March...

Mercia Asset Management released its trading summary for the financial year ended 31 March on Wednesday, with organic fund inflows surpassing £0.5bn, marking a record and reflecting a 40% surge in third-party funds under management since the start of the financial year.

The Chicago White Sox signed outfielder Robbie Grossman to a minor league contract when they should be finalizing their Opening Day roster.

The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: ---------- Vinanz Ltd - Virgin-Islands-based Bitcoin mining company...

Mercia Asset Management PLC (AIM:MERC) has been appointed to manage the capital of three funds of the British Business Bank, the state-owned lender used to...

Mercia Asset Management PLC on Thursday said it has been selected to manage three British Business Bank Midlands funds. The Warwickshire, England-based specialist asset managers said the new...

MIP Discovery, a developer of non-biological affinity reagents designed to accelerate the production of cell and gene therapies, has closed a £7 million Series A financing round, led by Mercia Ventures.